New York EzriCare and Delsam Eye Products Lawsuit Attorneys

Rheingold Giuffra Ruffo Plotkin & Hellman LLP is actively representing individuals affected by harmful EzriCare and Delsam Pharma eye drops, which have been linked to serious bacterial infections, including Pseudomonas aeruginosa.

EzriCare and Delsam Pharma Artificial Tears, commonly sold over the counter, have been associated with outbreaks of antibiotic-resistant bacteria, posing significant health risks to consumers.

Infections Associated with EzriCare and Delsam Eye Products

The presence of Pseudomonas aeruginosa in these eye drops has led to severe infections, including corneal ulcers and keratitis, with potential complications such as permanent vision loss, hospitalization, and death.

• Case Study in Cleveland, Ohio: A case study from November 2022 in Cleveland, Ohio, highlighted a 72-year-old patient diagnosed with a corneal ulcer caused by Pseudomonas aeruginosa, traced back to contaminated eye drops. This underscores the severe consequences of using compromised eye products.¹
• Challenges in Diagnosis and Treatment: Pseudomonas aeruginosa infections in the eye are rare, making diagnosis and treatment challenging. Specialized care and strong antibiotics are often required, indicating the severity of the infection and the limitations of available treatments.
• Importance of Awareness and Vigilance: Despite warnings from the CDC and FDA and the removal of contaminated products from stores, there remains a risk as some consumers may still possess them. Raising awareness among healthcare professionals and consumers about the dangers of tainted eye drops is crucial to prevent similar incidents.

Legal Action and Compensation

Individuals who have experienced complications after using EzriCare and Delsam Pharma eye drops may be eligible to pursue significant compensation through legal action. Our experienced New York attorneys are dedicated to helping victims seek justice and receive the compensation they deserve for their injuries and losses.